TY - JOUR
T1 - The role of IL-17 in the association between pneumococcal pneumonia and allergic sensitization
AU - Zhao, Hongxia
AU - Kang, Cheol In
AU - Rouse, Mark S.
AU - Patel, Robin
AU - Kita, Hirohito
AU - Juhn, Young J.
PY - 2011
Y1 - 2011
N2 - Interleukin- (IL-) 17 is important in the development of asthma and host defense against pneumococci. We determined the role of IL-17 in the risk of pneumococcal pneumonia. We challenged mice intranasally with a bioluminescent Streptococcus pneumoniae strain after sensitization and challenge with ovalbumin (OVA). We measured the levels of cytokines, including IL-17 (pg/mL), in the lung homogenate in experimental mice with and without OVA sensitization/ challenge, as well as those with and without pneumococcal pneumonia. IL-17 levels were significantly lower in OVA-sensitized/challenged mice (9.69 ± 1.49), compared to the control mice (20.92 ± 1.82, P < 0.001). In our overall analysis, including IL-4 and IL-17 levels and OVA sensitization/ challenge, IL-4 levels (OR: 81.9, 95%CI: 4.3-1523 per increment of 1.0pg/mL, P = 0.003) were more significant than IL-17 levels (OR: 1.1, 95%CI: 1.03-1.17 per increment of 1.0pg/mL, P = 0.003) in determining the risk of pneumococcal pneumonia. IL-17 levels result in a much smaller impact on the risk for pneumococcal pneumonia, compared to IL-4 levels.
AB - Interleukin- (IL-) 17 is important in the development of asthma and host defense against pneumococci. We determined the role of IL-17 in the risk of pneumococcal pneumonia. We challenged mice intranasally with a bioluminescent Streptococcus pneumoniae strain after sensitization and challenge with ovalbumin (OVA). We measured the levels of cytokines, including IL-17 (pg/mL), in the lung homogenate in experimental mice with and without OVA sensitization/ challenge, as well as those with and without pneumococcal pneumonia. IL-17 levels were significantly lower in OVA-sensitized/challenged mice (9.69 ± 1.49), compared to the control mice (20.92 ± 1.82, P < 0.001). In our overall analysis, including IL-4 and IL-17 levels and OVA sensitization/ challenge, IL-4 levels (OR: 81.9, 95%CI: 4.3-1523 per increment of 1.0pg/mL, P = 0.003) were more significant than IL-17 levels (OR: 1.1, 95%CI: 1.03-1.17 per increment of 1.0pg/mL, P = 0.003) in determining the risk of pneumococcal pneumonia. IL-17 levels result in a much smaller impact on the risk for pneumococcal pneumonia, compared to IL-4 levels.
UR - http://www.scopus.com/inward/record.url?scp=84862938042&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862938042&partnerID=8YFLogxK
U2 - 10.1155/2011/709509
DO - 10.1155/2011/709509
M3 - Article
C2 - 22164165
AN - SCOPUS:84862938042
SN - 1687-918X
JO - International Journal of Microbiology
JF - International Journal of Microbiology
M1 - 709509
ER -